CVC  Baxter Ventures

http://www.baxter.com/inside-baxter/science/p rograms/baxter-ventures.page





     Office Locations:

One Baxter Parkway
Deerfield, IL 60015
Phone: 224-948-2000

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Baxter Ventures was created in 2011 by Baxter International which has an 80-year legacy of healthcare innovation and saving and sustaining lives worldwide. With up $200 million in capital, Baxter Ventures invests in companies with innovative technologies, products and therapies with the ability to improve patient care globally and maximize value for investors and entrepreneurs. The firm's focus includes therapeutic areas complementary to those of Baxter's Medical Products and BioScience businesses. Areas of interest include: Acute and Intensive Care Pharmaceuticals, Anesthesia, BioSurgery, Clinical Nutrition, Critical Care, Fluid Management Systems, Hematologic Malignancies, Hematology/Hemophilia, Home Care Therapies, Immunology/ Inflammation, Infusion Systems/IV Tubing, Oncology, Pharmaceuticals/ Solutions/ Drug Delivery, Pulmonology, Rare/Orphan Diseases, Regenerative Medicine, Renal/ Dialysis Drugs and Devices, and Vaccines.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Ellen (Bradford) McIntosh Corporate Vice President, Associate General Counsel and Corporate Secretary
    Paul E. Martin Corporate Vice President and Chief Information Officer
    Scott Bohaboy CVP, Treasurer and Head of Investor Relations
    Scott Pleau Corporate Vice President of Global Operations and Company Officer
    Sean Martin Corporate Vice President and General Counsel

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/31/2017


      VitalConnect


      CA


      $38,000,000


      Series C


     

    Portfolio companies include:

     

    Recent News: